Shanghai INT Medical Instruments Co (HKSE:01501) Valuation Rank

View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Shanghai INT Medical Instruments Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai INT Medical Instruments Co (HKSE:01501) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803

Website

https://www.kdl-int.com

Shanghai INT Medical Instruments Co Ltd formerly Shanghai Kindly Medical Instruments Co Ltd is a manufacturer of cardiovascular interventional devices, which are mainly used in cardiovascular surgeries, and in particular, PCI procedures in China. It is engaged in the sales, manufacture, research, and development of cardiovascular interventional medical devices as well as related accessories and molds. It is also engaged in the research and development of other interventional and implantable medical devices, such as neurological interventional medical devices and endocardia implantable medical devices, among others. Geographically, it has operations in Mainland China, Europe, the United States, and Other countries.

Executives

China Orient Asset Management (international) Holding Limited	2201 Interest of corporation controlled by you
Jpmorgan Chase & Co.	2106 Person having a security interest in shares
Zhao Wei	2202 Interest of your spouse
Ningbo Huaige Gongxin Equity Investment Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Ningbo Huaige Health Investment Management Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Ningbo Huaige Taiyi Equity Investment Partnership (limited Partnership)	2101 Beneficial owner
Wang Kai	2201 Interest of corporation controlled by you
Zhao Wei	2202 Interest of your spouse
Shanghai Gongye Investment Co., Ltd.	2201 Interest of corporation controlled by you
Zhang Wei	2501 Other
Worldwide Healthcare Trust Plc	2101 Beneficial owner
Orbimed Capital Llc	2102 Investment manager
Zheng Aiping	2501 Other
Zhang Xianmiao	2501 Other
Zhang Wei	2501 Other